Prof. Hui Wu 吴慧
Chief Physician, Professor
Department of Radiation Oncology, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and pain management for head and neck tumors, esophageal cancer, lung cancer, brain metastases, bone metastasis pain, and breast cancer.
Dr. Wu is Chief Physician, Professor, and Deputy Director of the Radiotherapy Center at Henan Cancer Hospital, holding a medical doctorate. Dr. Wu serves as Deputy Director of the Thyroid Institute at Henan Cancer Research Institute and leads clinical teaching for oncology graduate students. Research includes national multi-center studies and National Natural Science Foundation projects. Dr. Wu has published 52 papers and two monographs.
Professional roles
- Youth Committee Member, Radiation Oncology Committee, Chinese Medical Association
- Committee Member, Radiation Oncology Committee, China Anti-Cancer Association
- Vice Chair, Radiation Oncology Committee, Henan Medical Association
Name order: in Chinese the family name comes first (Wu Hui). Papers usually list the name as Hui Wu or Wu H.
Selected publications
35 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Phys Imaging Radiat Oncol, 2026 (senior author): Proton Bragg peak flash stereotactic radiosurgery for recurrent glioblastoma reirradiation. PubMed 42630800
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Advancing Proton FLASH Radiation Therapy: Innovations, Techniques, and Clinical Potentials. PubMed 40513679
- J Cancer Res Clin Oncol, 2025 (senior author): Transcriptional regulation of nucleotide metabolism in medulloblastoma subtypes and prognostic implications analyzed by RNA-Seq. PubMed 41055774
- Oral Dis, 2025 (senior author): Predictive Value of (18)F-FDG PET/CT in LA-HNSCC Patients Undergoing Neoadjuvant Chemoimmunotherapy: A Prospective Study. PubMed 39962918
- J Cancer Res Clin Oncol, 2024 (senior author): Metabolomic profiling of childhood medulloblastoma: contributions and relevance to diagnosis and molecular subtyping. PubMed 39441459
- Cancers (Basel), 2024 (senior author): The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation. PubMed 39409872
- Transl Cancer Res, 2024 (senior author): Prognostic significance of alterations in fibrinogen level and fibrinogen-to-lymphocyte ratio after radiotherapy on survival outcomes in glioblastoma. PubMed 38737673
- Int J Immunopathol Pharmacol, 2024 (senior author): A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy. PubMed 38687369
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion